Product NDC: | 31722-543 |
Proprietary Name: | Indomethacin |
Non Proprietary Name: | Indomethacin |
Active Ingredient(s): | 50 mg/1 & nbsp; Indomethacin |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 31722-543 |
Labeler Name: | Camber Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091240 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111101 |
Package NDC: | 31722-543-30 |
Package Description: | 12 BOTTLE in 1 CASE (31722-543-30) > 30 CAPSULE in 1 BOTTLE |
NDC Code | 31722-543-30 |
Proprietary Name | Indomethacin |
Package Description | 12 BOTTLE in 1 CASE (31722-543-30) > 30 CAPSULE in 1 BOTTLE |
Product NDC | 31722-543 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Indomethacin |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20111101 |
Marketing Category Name | ANDA |
Labeler Name | Camber Pharmaceuticals |
Substance Name | INDOMETHACIN |
Strength Number | 50 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |